vs

Side-by-side financial comparison of Loews Corporation (L) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.

BeOne Medicines Ltd. is the larger business by last-quarter revenue ($1.5B vs $827.0M, roughly 1.8× Loews Corporation). Loews Corporation runs the higher net margin — 48.6% vs 4.4%, a 44.2% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs 4.8%). Loews Corporation produced more free cash flow last quarter ($426.0M vs $379.8M). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs 7.9%).

Loews Corporation is a diversified US-based conglomerate that operates across multiple key industry segments through its subsidiaries. Its core business lines include property and casualty insurance, natural gas pipeline transportation, hospitality services, and upstream oil and gas exploration and production, primarily serving commercial, consumer and industrial clients across North American markets.

BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.

L vs ONC — Head-to-Head

Bigger by revenue
ONC
ONC
1.8× larger
ONC
$1.5B
$827.0M
L
Growing faster (revenue YoY)
ONC
ONC
+28.0% gap
ONC
32.8%
4.8%
L
Higher net margin
L
L
44.2% more per $
L
48.6%
4.4%
ONC
More free cash flow
L
L
$46.2M more FCF
L
$426.0M
$379.8M
ONC
Faster 2-yr revenue CAGR
ONC
ONC
Annualised
ONC
41.2%
7.9%
L

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
L
L
ONC
ONC
Revenue
$827.0M
$1.5B
Net Profit
$402.0M
$66.5M
Gross Margin
90.5%
Operating Margin
65.4%
12.4%
Net Margin
48.6%
4.4%
Revenue YoY
4.8%
32.8%
Net Profit YoY
115.0%
143.8%
EPS (diluted)
$1.93
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
L
L
ONC
ONC
Q4 25
$827.0M
$1.5B
Q3 25
$732.0M
$1.4B
Q2 25
$769.0M
$1.3B
Q1 25
$846.0M
$1.1B
Q4 24
$789.0M
$1.1B
Q3 24
$683.0M
$1.0B
Q2 24
$711.0M
$929.2M
Q1 24
$710.0M
$751.7M
Net Profit
L
L
ONC
ONC
Q4 25
$402.0M
$66.5M
Q3 25
$504.0M
$124.8M
Q2 25
$391.0M
$94.3M
Q1 25
$370.0M
$1.3M
Q4 24
$187.0M
$-151.9M
Q3 24
$401.0M
$-121.3M
Q2 24
$369.0M
$-120.4M
Q1 24
$457.0M
$-251.2M
Gross Margin
L
L
ONC
ONC
Q4 25
90.5%
Q3 25
86.1%
Q2 25
87.5%
Q1 25
85.2%
Q4 24
85.8%
Q3 24
83.0%
Q2 24
85.1%
Q1 24
83.4%
Operating Margin
L
L
ONC
ONC
Q4 25
65.4%
12.4%
Q3 25
94.1%
11.5%
Q2 25
70.1%
6.7%
Q1 25
60.8%
1.0%
Q4 24
23.8%
-7.0%
Q3 24
80.5%
-12.0%
Q2 24
71.3%
-11.5%
Q1 24
88.6%
-34.8%
Net Margin
L
L
ONC
ONC
Q4 25
48.6%
4.4%
Q3 25
68.9%
8.8%
Q2 25
50.8%
7.2%
Q1 25
43.7%
0.1%
Q4 24
23.7%
-13.5%
Q3 24
58.7%
-12.1%
Q2 24
51.9%
-13.0%
Q1 24
64.4%
-33.4%
EPS (diluted)
L
L
ONC
ONC
Q4 25
$1.93
$0.05
Q3 25
$2.43
$0.08
Q2 25
$1.87
$0.06
Q1 25
$1.74
$0.00
Q4 24
$0.87
$-0.10
Q3 24
$1.82
$-0.09
Q2 24
$1.67
$-0.09
Q1 24
$2.05
$-0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
L
L
ONC
ONC
Cash + ST InvestmentsLiquidity on hand
$6.0B
$4.5B
Total DebtLower is stronger
$8.4B
$836.4M
Stockholders' EquityBook value
$18.7B
$4.4B
Total Assets
$86.3B
$8.2B
Debt / EquityLower = less leverage
0.45×
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
L
L
ONC
ONC
Q4 25
$6.0B
$4.5B
Q3 25
$5.4B
$4.0B
Q2 25
$4.5B
$2.8B
Q1 25
$4.4B
$2.5B
Q4 24
$4.6B
$2.6B
Q3 24
$5.2B
$2.7B
Q2 24
$4.9B
$2.6B
Q1 24
$5.4B
$2.8B
Total Debt
L
L
ONC
ONC
Q4 25
$8.4B
$836.4M
Q3 25
$8.4B
Q2 25
$7.9B
Q1 25
$8.4B
Q4 24
$8.9B
Q3 24
$8.8B
Q2 24
$8.6B
Q1 24
$8.4B
Stockholders' Equity
L
L
ONC
ONC
Q4 25
$18.7B
$4.4B
Q3 25
$18.3B
$4.1B
Q2 25
$17.5B
$3.8B
Q1 25
$17.2B
$3.5B
Q4 24
$17.1B
$3.3B
Q3 24
$17.4B
$3.4B
Q2 24
$16.4B
$3.4B
Q1 24
$16.2B
$3.4B
Total Assets
L
L
ONC
ONC
Q4 25
$86.3B
$8.2B
Q3 25
$85.9B
$7.6B
Q2 25
$84.7B
$6.3B
Q1 25
$83.1B
$5.8B
Q4 24
$81.9B
$5.9B
Q3 24
$83.6B
$5.8B
Q2 24
$81.1B
$5.7B
Q1 24
$80.9B
$5.7B
Debt / Equity
L
L
ONC
ONC
Q4 25
0.45×
0.19×
Q3 25
0.46×
Q2 25
0.45×
Q1 25
0.49×
Q4 24
0.52×
Q3 24
0.51×
Q2 24
0.52×
Q1 24
0.52×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
L
L
ONC
ONC
Operating Cash FlowLast quarter
$617.0M
$417.3M
Free Cash FlowOCF − Capex
$426.0M
$379.8M
FCF MarginFCF / Revenue
51.5%
25.4%
Capex IntensityCapex / Revenue
23.1%
2.5%
Cash ConversionOCF / Net Profit
1.53×
6.28×
TTM Free Cash FlowTrailing 4 quarters
$2.7B
$941.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
L
L
ONC
ONC
Q4 25
$617.0M
$417.3M
Q3 25
$920.0M
$402.6M
Q2 25
$1.0B
$263.6M
Q1 25
$736.0M
$44.1M
Q4 24
$941.0M
$75.2M
Q3 24
$934.0M
$188.4M
Q2 24
$952.0M
$-95.6M
Q1 24
$198.0M
$-308.6M
Free Cash Flow
L
L
ONC
ONC
Q4 25
$426.0M
$379.8M
Q3 25
$764.0M
$354.5M
Q2 25
$872.0M
$219.8M
Q1 25
$638.0M
$-12.3M
Q4 24
$767.0M
$-17.3M
Q3 24
$794.0M
$54.7M
Q2 24
$793.0M
$-205.5M
Q1 24
$39.0M
$-465.1M
FCF Margin
L
L
ONC
ONC
Q4 25
51.5%
25.4%
Q3 25
104.4%
25.1%
Q2 25
113.4%
16.7%
Q1 25
75.4%
-1.1%
Q4 24
97.2%
-1.5%
Q3 24
116.3%
5.5%
Q2 24
111.5%
-22.1%
Q1 24
5.5%
-61.9%
Capex Intensity
L
L
ONC
ONC
Q4 25
23.1%
2.5%
Q3 25
21.3%
3.4%
Q2 25
17.4%
3.3%
Q1 25
11.6%
5.0%
Q4 24
22.1%
8.2%
Q3 24
20.5%
13.3%
Q2 24
22.4%
11.8%
Q1 24
22.4%
20.8%
Cash Conversion
L
L
ONC
ONC
Q4 25
1.53×
6.28×
Q3 25
1.83×
3.22×
Q2 25
2.57×
2.79×
Q1 25
1.99×
34.71×
Q4 24
5.03×
Q3 24
2.33×
Q2 24
2.58×
Q1 24
0.43×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

L
L

Transportation And Storage Of Natural Gas And NG Ls And Ethane Supply And Transportation Services$601.0M73%
Lodging And Related Services$226.0M27%

ONC
ONC

Segment breakdown not available.

Related Comparisons